A pair of Missouri medical marijuana initiative campaigns have handed in lots and lots of signatures, a federal appeals court upheld a DEA rule that CBD is a Schedule I controlled substance, the Utah initiative campaign gets organized opposition, and more.
Black drivers in Ohio are more likely to get drug dogs sicced on them than white ones, official data shows. (Wikimedia)
Two separate Missouri medical marijuana initiatives appear set to qualify for the November ballot, the Utah medical marijuana initiative is generating organized opposition -- including the DEA -- Canada's prime minister says it's full steam ahead for marijuana legalization, and more.
Mitch McConnell just says no, a House committee advances a VA medical marijuana bill, Pennsylvania's governor and attorney general aren't down with a Philadelphia safe injection site, and more.
Vancouver's InSite safe injection site. Could New York City be next? (Wikimedia)
Colorado could become the first state with a marijuana social consumption law, a new poll suggests New Yorkers are ready to free the weed, New York City's mayor gets behind safer injection facilities, a leading Colombian presidential contender trashes the drug war, and more.
New York City Mayor Bill de Blasio comes out for safe injection sites. (Flickr)
Pre-employment workplace drug testing for marijuana appears to be going out of style, a federal appeals court disappoints on scheduling cannabinoids, a Vermont saliva drug testing bill is killed, and more.
A major Las Vegas strip casino gives up on pre-employment screening for marijuana. (Creative Commons)
A new report finds legal marijuana makes a marginal contribution to state budgets, a major Las Vegas casino quits pre-employment testing for marijuana, an Australian Senate panel advances a controversial plan to drug test welfare recipients, and more.
Rep. Earl Blumenauer (D-OR) is a founding member of the new congressional cannabis caucus. (wikimedia.org)
A bipartisan effort to goose federal marijuana reforms is underway, a bill that would establish a hemispheric drug policy review heads for the president's desk, the Israeli anti-drug body makes a surprise move, and more.